Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 20/20 | 0.78 |
| ▸ | BACE2 | Q9Y5Z0 | 7/20 | 0.67 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2620191 | 1.00 | BACE1 (0.78) | BACE1BACE2KCNH2CYP2D6CYP1A2 | |
| SCHEMBL2620172 | 1.00 | BACE1 (0.78) | BACE1BACE2KCNH2CYP2D6CYP1A2 | |
| SCHEMBL2932438 | 1.00 | BACE1 (0.78) | BACE1BACE2KCNH2CYP2D6CYP1A2 | |
| SCHEMBL2622958 | 0.93 | BACE1 (0.77) | BACE1BACE2KCNH2CYP2D6CYP1A2 | |
| SCHEMBL2622956 | 0.93 | BACE1 (0.77) | BACE1BACE2KCNH2CYP2D6CYP1A2 | |
| SCHEMBL2926835 | 0.92 | BACE1 (0.73) | BACE1BACE2KCNH2CYP2D6CYP1A2 | |
| SCHEMBL2620273 | 0.92 | BACE1 (0.73) | BACE1BACE2KCNH2CYP2D6CYP1A2 | |
| SCHEMBL2620276 | 0.92 | BACE1 (0.73) | BACE1BACE2KCNH2CYP2D6CYP1A2 | |
| SCHEMBL2620127 | 0.90 | BACE1 (0.73) | BACE1BACE2KCNH2CYP2D6CYP1A2 | |
| SCHEMBL2926554 | 0.90 | BACE1 (0.73) | BACE1BACE2KCNH2CYP2D6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009091016-A1 | CONDENSED AMINODIHYDROTHIAZINE DERIVATIVE | EISAI R & D MANAGEMENT CO., LTD. (JP) | 2009-07-23 | — | — | WO | disclosed |